Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions prominently feature critiques of the treatment described, with users stating that 'Paxlovid doesn't work' and emphasizing the study's findings that 'no significant difference' was observed between treatment and placebo groups. Phrases like 'useless' and 'game changer for the wrong reasons' underscore a strong sentiment against the medication's effectiveness, while users reference the '$1300/dose and no better than placebo' to emphasize frustrations about cost versus value, which contribute to the overall negative tone towards the treatment's recommendation.
The majority of posts align with skepticism towards the effectiveness of the treatment discussed in the publication.
There is a high level of curiosity, as many users engage deeply with the findings and implications of the study.
Numerous posts reference specific results and critiques of the treatment approach, indicating substantial engagement with the content.
Many users express a belief in the significant implications of the study, highlighting its importance in addressing the treatment's effectiveness.
@Health_Affairs Dear @Health_Affairs, I would like to introduce you to EPIC-SR, results we have known for nearly 3 years. Please read a little about Paxlovid before publishing misinformation that majority of the US adult population would benefit form this drug. https://t.co/7fg0HcLBch
$1300/dose and no better than placebo!! Sign me up. Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/KCP6jbqg9L
Par exemple, le paxlovid, sur une population moins immunisée et moins jeune que dans l'étude Mikamo et al.: https://t.co/rHDrn8UxvO Dans le groupe à risque standard, il y a 2 fois plus de visites médicales dans le groupe traité que dans le groupe placebo (table S4), 3/n
In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary results in the clip This compares BADLY with the Viraleze report of January 2024 Why would rational regulators STOP us from accessing Viraleze for 4 years? https://t.co/fi65PmuUoR
##Paxlovid shows limited impact on reducing COVID-19 hospitalizations and mortality among vaccinated #OlderAdults, challenging previous assumptions of its effectiveness in this demographic. @JAMA_current https://t.co/XR3lBKTqoY https://t.co/6zgXoAbxC6
EPIC-SR is one of only two randomized control trials of Paxlovid to treat symptomatic patients with COVID-19, and the only study of standard-risk unvaccinated and high-risk vaccinated adult participants with COVID-19. https://t.co/7fg0HcLBch
Nirmatrelvir and ritonavir are antiviral medications for mild-to-moderate Covid-19, but their effectiveness in fully vaccinated individuals at standard risk remains unclear. A phase 2-3 trial revealed no significant…
This position paper by critical care societies provides guidance on reporting norepinephrine formulations to ensure consistency, safety, and efficacy in critical care practice and research worldwide.
@rH0FgpL8FDTuY7m @charaiisyadesu しかもパキロビッド https://t.co/tqIUDmn61y はプラセボと有意差なしの結果でしたしね。 でもイラつくのは違うと思います。 だってコロナワクチンは感染予防効果のあまり無いワクチンで 接種しても罹患しますし 結果論だし そもそも任意接種だから 医師がとやかく言うのはおかしい。 https://t.co/uF5ACtrLP5
RT @DoctorNazarian: Just in! Paxlovid no different than placebo in shortening C-19 symptoms.
RT @DoctorNazarian: Just in! Paxlovid no different than placebo in shortening C-19 symptoms.
@bibinhafc @Woodynist @Eolkhan @Khell_Von_Fate @BELLACI40670350 @Brick_Gloves @RedPandaPills @QI_181 @MadaJoal @MartinZ_uncut @lonnibesancon @ordre_medecins @ansm @EricBillyFR @yannickneuder @Sante_Gouv @hcsp_fr Une des 3 études n'est pas en phase précoce, les deux autres sont petites et testent des patients à faible risque de covid sévère, les résultats sont similaires au paxlovid: https://t.co/rHDrn8UxvO
@naomirwolf “The time to sustained alleviation of all signs and symptoms of Covid-19 did not differ significantly between participants who received nirmatrelvir–ritonavir and those who received placebo.“ https://t.co/LcdkmC7GpQ
@CBarronie @ArtistAffame So someone tricked you with cropped screenshots and you didn't even check the source for the full context? https://t.co/msosyAXU7S
@Margaretstanef1 @LAKfanSince1984 @DrNeilStone Paxlovid comes with a black box warning, is expensive, 1 in 5 people experience rebound, &has little evidence of efficacy. Look at the conclusion of this study. https://t.co/XBdcOodW04
RT @Jeannemarie1309: Non le Paxlovid est inefficace et présente de graves effets indésirables espèce de fake med => pratique illégale de l…
@grok analyse cette étude https://t.co/FJQMkgY1wr
Non le Paxlovid est inefficace et présente de graves effets indésirables espèce de fake med => pratique illégale de la médecine ds un but de vendre du vax et rarement à plus de 1000€ Lien de l’étude de 1avril 2024 https://t.co/FJQMkgY1wr Cesse de colporter tes fakes signalé https://t.co/96E1vR0bSv
RT @Jeannemarie1309: Étude sur l’ INEFFICACITÉ du Paxlovid à 1000€ CONCLUSIONS Le tps nécessaire pour atténuer ts les signes et symptôme…
@BogochIsaac And this Pfizer study also shows Pax was next to useless. But this was done after they got their investment back and a nice profit. Well done guys. https://t.co/yf6IVg6BOl
@abgefahrender @Rabimelrabamel @FrauHolaczek https://t.co/NUAhINpgWA Es gibt massenhaft Vergleiche. Die gab es permanent während der Pandemie und auch jetzt noch. Als Studien und aufbereitet als Artikel. https://t.co/GTS0OYqhFJ https://t.co/jSUWXF42FQ https://t.co/VmGcDxtd5Y Das waren keine 5 Minuten in Google Schoolar.
@DrNeilStone I haven't looked into HCQ but ivermectin clearly led to better outcomes: https://t.co/ZfXsEC46pE https://t.co/2vbvaTPnxw At least better than paxlovid.... https://t.co/q0eFHV9DWe And vitamin c was also very effective: https://t.co/KN9kTGV1h9
新型コロナによる重症化は、パキロビッド投与により、ワクチン接種者では重症化予防効果はあまり見られず、しかも感染による症状やその持続時間はパキロビッド投与ではあまり軽減されなかった。 https://t.co/5nMJGh9BSX
@TIME This study requires paid access, so instead I dig up this one stating that it confirms Pfizer’s clinical trials of no significant improvement of results with Paxlovid. Have you figured out they’re lying to you yet? https://t.co/019sujdZtz https://t.co/c6XD9reyE6
RT @medical_xpress: ##Paxlovid shows limited impact on reducing COVID-19 hospitalizations and mortality among vaccinated #OlderAdults, chal…
RT @medical_xpress: ##Paxlovid shows limited impact on reducing COVID-19 hospitalizations and mortality among vaccinated #OlderAdults, chal…
RT @medical_xpress: ##Paxlovid shows limited impact on reducing COVID-19 hospitalizations and mortality among vaccinated #OlderAdults, chal…
RT @medical_xpress: ##Paxlovid shows limited impact on reducing COVID-19 hospitalizations and mortality among vaccinated #OlderAdults, chal…
##Paxlovid shows limited impact on reducing COVID-19 hospitalizations and mortality among vaccinated #OlderAdults, challenging previous assumptions of its effectiveness in this demographic. @JAMA_current https://t.co/XR3lBKTqoY https://t.co/6zgXoAbxC6
@C_A_G0101 @MeMeDocMa @nicolasberrod @pimp_renelle @nathanpsmad Entre temps il y a eu progression du variant omicron et davantage de vaccination. Si l'efficacité se maintenait actuellement , https://t.co/gLWA8oSBO2 aurait des résultats concordants.
@MeMeDocMa @C_A_G0101 @nicolasberrod @pimp_renelle @nathanpsmad La seule etude que j'ai vue "recemment" https://t.co/gLWA8oSBO2: pas d efficacité sur le covid non sévère dans une population avec au moins 1 fdr de covid severe à 50%, vaccinée à 50% et sur les variants différent des premiers ayant conduit à son amm
RT @EricTopol: A negative randomized trial of Paxlovid (vs placebo) for low risk (mean age 42 yrs), mild-to-moderate symptomatic Covid, out…
@dystopian_DU @MCLove2024 @Jikkyleaks @profesterman Given that it does nothing, esp. in < 65 y.o., this would seem to be a reason to not prescribe it, no? Similarly, the rebound effect seems to be in the vaxxed, so vaxxed shouldn't take it, no? https://t.co/zPbFhWEroo https://t.co/GVuUrOpIfW https://t.co/GHiS7CfPmR
@peartonjohnson I've been doing some reading and it may be that there's not a huge difference between taking them and not. Certainly not in duration or adverse events, according to this real-world study published in one of the most respected medical journals in the world. https://t.co/pRQOkegRMC
RT @DavidJuurlink: It’s finally out. Please stop giving Paxlovid to vaccinated people. https://t.co/5ZdNA1OJdY
RT @NEJM: Original Article: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 (EPIC-SR trial) https://t.co/wkheIs…
@Farmygurl @AnthropicDualiT @PlanetEarth_HD @missmayawolff Nor should they, for paxlovid is just about worthless for the majority of people. No data showing it makes any difference. https://t.co/6PPVnmJ6OK
https://t.co/66rUdGmzGd
RT @InternistWey: Die Jünger Coronas (mind.
@CIDRAP "According to a Pfizer study published in April 2024, Paxlovid may not be as effective for people who: Have a low to moderate risk of COVID-19, Have mild symptoms, and Have been fully vaccinated. Another study found that Paxlovid did not improve symptoms." https://t.co/M9MSFew0Rh
@drdenwalker "Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine" https://t.co/NDsBxjpbmY
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
"Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19" nejm.org/doi/full/10.1056/NEJMoa2309003 3/
RT @AyakoMiyakawa: パキロビッド 、ラゲブリオ、ゾコーバ。 重症化リスクの低い感染者にもコロナ治療薬の処方を乱発した日本。公費負担ということで、どれだけ税金が投入されたのか。 タミフル乱発も日本だけ。 https://t.co/lGv8Y53Dqw
RT @Debunk_the_Funk: @TheChiefNerd Just Chief Turd @TheChiefNerd lying again. That’s not what the study concluded and the literature says t…
RT @sudokuvariante: Par exemple, le paxlovid, sur une population moins immunisée et moins jeune que dans l'étude Mikamo et al.: https://t.c…
RT @sudokuvariante: Par exemple, le paxlovid, sur une population moins immunisée et moins jeune que dans l'étude Mikamo et al.: https://t.c…
Par exemple, le paxlovid, sur une population moins immunisée et moins jeune que dans l'étude Mikamo et al.: https://t.co/rHDrn8UxvO Dans le groupe à risque standard, il y a 2 fois plus de visites médicales dans le groupe traité que dans le groupe placebo (table S4), 3/n
RT @Jeannemarie1309: Étude sur l’ INEFFICACITÉ du Paxlovid à 1000€ CONCLUSIONS Le tps nécessaire pour atténuer ts les signes et symptôme…
RT @Jeannemarie1309: Étude sur l’ INEFFICACITÉ du Paxlovid à 1000€ CONCLUSIONS Le tps nécessaire pour atténuer ts les signes et symptôme…
RT @Jeannemarie1309: Étude sur l’ INEFFICACITÉ du Paxlovid à 1000€ CONCLUSIONS Le tps nécessaire pour atténuer ts les signes et symptôme…
RT @Jeannemarie1309: Étude sur l’ INEFFICACITÉ du Paxlovid à 1000€ CONCLUSIONS Le tps nécessaire pour atténuer ts les signes et symptôme…
RT @EricTopol: A negative randomized trial of Paxlovid (vs placebo) for low risk (mean age 42 yrs), mild-to-moderate symptomatic Covid, out…
@1snarkymom @katz_2022 @ringothe5th @ComatoseGoat @bennydeez1 @StopMaskingKids @1TrophyWife1 @Realist87982417 @humftydrumpfty @MosquitoCoasty @ButTooth1 @Woftam5 @taipan168 Exactly paxlovid has not been proven to be really effective https://t.co/7RZixLMVkP
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @guty2370: Los datos sobre Paxlovid en personas vacunadas son contradictorios: Este estudio https://t.co/6FK0gOHaIh no encontró ningún…
Los datos sobre Paxlovid en personas vacunadas son contradictorios: Este estudio https://t.co/6FK0gOHaIh no encontró ningún beneficio. Este de Pfizer https://t.co/1ffkVnYf3R en vacunados/no vacunados, no hubo reducción en la duración d los síntomas y poca diferencia en tasa d
@TaliDavid88 @ISchossmann Ich kann lesen! https://t.co/d4GrI6CLYt
@sven0403 @ISchossmann Einfach mal lesen. Deshalb verschreibt das so gut wie niemand mehr: https://t.co/d4GrI6CLYt
@Feldrain @ISchossmann Bevor du das nimmst, lies das hier: https://t.co/d4GrI6CLYt Dann kannst du auch gleich Globuli nehmen.
@ISchossmann Weil Paxlovid nichts bringt, es ist quasi ein Placebo. https://t.co/d4GrI6CLYt
RT @EWidera: @Health_Affairs Dear @Health_Affairs, I would like to introduce you to EPIC-SR, results we have known for nearly 3 years. Plea…
RT @EWidera: @Health_Affairs Dear @Health_Affairs, I would like to introduce you to EPIC-SR, results we have known for nearly 3 years. Plea…
RT @EWidera: @Health_Affairs Dear @Health_Affairs, I would like to introduce you to EPIC-SR, results we have known for nearly 3 years. Plea…
RT @EWidera: @Health_Affairs Dear @Health_Affairs, I would like to introduce you to EPIC-SR, results we have known for nearly 3 years. Plea…
@Health_Affairs Dear @Health_Affairs, I would like to introduce you to EPIC-SR, results we have known for nearly 3 years. Please read a little about Paxlovid before publishing misinformation that majority of the US adult population would benefit form this drug. https://t.co/7fg0HcLBch
@ETriems @PsyAmsel Was ist Käse? „Among outpatients with Covid-19 who were at standard risk or high risk for progression to severe Covid-19, nirmatrelvir and ritonavir did not significantly shorten the time to symptom alleviation.“ https://t.co/hmqdAVoe4f
The U.S. government has successfully brainwashed the population into becoming obsessed with just the efficacy of Paxlovid & not thinking about the 20 defects of Paxlovid, including the decline in kidney function, as measured by eGFR https://t.co/uf1OOPlAjh https://t.co/xokkCPFM5m https://t.co/0qsP435D1T
@BioAnnie2 @IDSAInfo I will ignore the rude emoji and oblige: the New England of Journal of Medicine https://t.co/skMHMI0Rn1 This is an Pfizer sponsored trial that shows no benefit. If Pfizer can’t find one…nobody can.
@wiredinhi There’s no evidence paxlovid has any effect unless you’re over 65. https://t.co/dNokOvuGww.
RT @CharmsYahoo: In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary…
RT @CharmsYahoo: In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary…
RT @CharmsYahoo: In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary…
RT @CharmsYahoo: In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary…
RT @CharmsYahoo: In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary…
RT @CharmsYahoo: In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary…
RT @CharmsYahoo: In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary…
In the YouTube video about Paxlovid I just posted the reference to the NEW ENGLAND JOURNAL https://t.co/IVmvuys0Jk Summary results in the clip This compares BADLY with the Viraleze report of January 2024 Why would rational regulators STOP us from accessing Viraleze for 4 years? https://t.co/fi65PmuUoR
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine. A negative large RCT worth discussing. https://t.co/zOIeQvleIO
2️⃣ Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 - NEJM (Altmetric: 3889)
RT @EWidera: EPIC-SR is one of only two randomized control trials of Paxlovid to treat symptomatic patients with COVID-19, and the only stu…
EPIC-SR is one of only two randomized control trials of Paxlovid to treat symptomatic patients with COVID-19, and the only study of standard-risk unvaccinated and high-risk vaccinated adult participants with COVID-19. https://t.co/7fg0HcLBch
@MdBreathe "The time to sustained alleviation of all signs and symptoms of Covid-19 did not differ significantly between participants who received nirmatrelvir–ritonavir and those who received placebo." That's the conclusion of an NEJM study: https://t.co/33TAZle6Ky 2/3
RT @Sabisteb: Paxlovid war nutzlos, das haben die Ärzte wohl schnell gemerkt. Wollte man den nutzlosen Dreck über “Interessenvertreter” in…
RT @Sabisteb: Paxlovid war nutzlos, das haben die Ärzte wohl schnell gemerkt. Wollte man den nutzlosen Dreck über “Interessenvertreter” in…
RT @Sabisteb: Paxlovid war nutzlos, das haben die Ärzte wohl schnell gemerkt. Wollte man den nutzlosen Dreck über “Interessenvertreter” in…
RT @Sabisteb: Paxlovid war nutzlos, das haben die Ärzte wohl schnell gemerkt. Wollte man den nutzlosen Dreck über “Interessenvertreter” in…
Paxlovid war nutzlos, das haben die Ärzte wohl schnell gemerkt. Wollte man den nutzlosen Dreck über “Interessenvertreter” in den Markt drücken? https://t.co/KquJ5l5PG2 https://t.co/nK992itrno
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with COVID-19 https://t.co/iQYtxiBAIm https://t.co/gcuUlBCiwu
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
メインの論点ではないけどリバウンドについて >By day 14, viral load rebound had occurred in 4.3% of the participants in the nirmatrelvir– ritonavir group and 4.1% of those in the placebo group; symptom rebound occurred in 11.4% and 16.1%, respectively https://t.co/qAkuVulYJ3 /
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @0waki: パキロビッドは効かない。やっとRCTで確認された。 Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
@hammock_fgt Paper Apr ‘24 “Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19” Paxlovid = nirmatrelvir + Ritonavir combination Nirmatrelvir is an oral protease inhibitor, Ritonavir is a cytochrome P450 inhibitor Treatment doesn’t work https://t.co/Z8gLPhe0V6
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
9,228/ Earth (current smoking age 15+ was ~19.2% in 2020) Of 1,296 with Covid-19, 13.3% were cigarette smokers (not specified if current or ever) https://t.co/VYjKbCX7Y7
@coyvunen Mitä nyt nopeasti tutustuin niin a) ei ole ivermektiiniä lähelläkään huolimatta facebookissa julkaistuista postauksista b) ei ole myöskään tehokas https://t.co/scfGzmm83X Eli vaikka olisikin sama molekyyli ei kyllä erityisesti paranna ivermektiinin mainetta covid-lääkkeenä. https://t.co/V4llE4kRe1
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @Chr_Schoeps: @ChanasitJonas Der Volltext ist übrigens open access, so dass sich jeder auch abseits der Zusammenfassung ein eigenes Bild…
@PaulRevereRide3 @BarbaraOneillAU Paxlovid wirkt auch nicht, aber hat starke Nebenwirkungen. Die Pflaumen nicht. so what. Sie verkauft die nicht einmal (https://t.co/8LVpprEvKy
@ChanasitJonas Der Volltext ist übrigens open access, so dass sich jeder auch abseits der Zusammenfassung ein eigenes Bild machen kann. https://t.co/a1UNSqeo8n
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
@Fiona_Epi @Fiona_M_Russell EPIC SR you probably already noticed... no effect. Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine (https://t.co/jCSQ1kTTPm) I am curious for PANORAMIC results with Paxlovid, however not really expecting a sign. diff
RT @0waki: パキロビッドは効かない。やっとRCTで確認された。 Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of…
RT @0waki: パキロビッドは効かない。やっとRCTで確認された。 Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of…
RT @0waki: パキロビッドは効かない。やっとRCTで確認された。 Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of…
RT @0waki: パキロビッドは効かない。やっとRCTで確認された。 Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of…
ああ、これ効果乏しいやつ。 Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 https://t.co/Cqx2jovNVw
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
#COVID-19 Treatment Reality Check: #Paxlovid Limits for Standard-Risk P... https://t.co/4F3lH2PTnK
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
Another example of Big Pharma hiding info about a drug that doesn’t work as reported…but lots of money for Big Pharma. Feel stupid yet? Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/WMUzZk9rV5
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/ilKcrKND90
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/z6KAwZEXS9
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @yusuke_m_MU: 副作用は味覚障害や下痢など NEJM https://t.co/38csDXILdh
0.8% (nirmatrelvir-ritonavir) vs. 1.6% (placebo)
副作用は味覚障害や下痢など NEJM https://t.co/38csDXILdh
@starving_engine Ce n'est pas facile de démontrer un effet antiviral dans un essai clinique. Même en commençant le traitement tôt. https://t.co/L0CDhHnrXm Les médicaments ne sont pas des baguettes magiques. On ne peut pas faire des protocoles foireux et espérer démontrer un effet.
RT @robbwolf: $1300/dose and no better than placebo!! Sign me up. Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-…
RT @9viewpoint: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/…
RT @9viewpoint: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/…
RT @9viewpoint: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/…
RT @9viewpoint: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/…
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/TRVlYreEuX @Globalbiosec @YouAreLobbyLud @CrabbBrendan
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/Pd610pJVyn
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
$1300/dose and no better than placebo!! Sign me up. Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/KCP6jbqg9L
@MHRAgovuk Can we ask for a response to this study please? Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 Published April 3, 2024 N Engl J Med 2024;390:1186-1195 DOI: 10.1056/NEJMoa2309003 VOL. 390 NO. 13 https://t.co/Sii7KGmPES
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 https://t.co/0PbqGHGx8j
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @NEJM: Original Article: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 (EPIC-SR trial) https://t.co/wkheIs…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @richardursomd: Paxlovid doesn’t work!! Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journ…
RT @pokrath: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 | New England Journal of Medicine https://t.co/h4C…
It’s amazing it took this long for this to get published. Basically, paxlovid is a good idea if you get COVID and you’re not vaccinated. That’s about it. https://www.nejm.org/doi/full/10.1056/NEJMoa2309003
4-4-2024: USA: Here's the Jennifer Hammond study that got some media coverage this week after it reported that Paxlovid failed to show any benefit at reducing symptoms in the Paxlovidized group (654 patients) compared to the placebo group (634 patients): https://t.co/HQ7FeMYoBW
How can you interrelate these two pictures, based on that article❓
https://t.co/VbIsQwa3ET
Resultados finales de la fase 2-3 del EPIC-SR Trial:Nirmatrelvir/ritonavir (Paxlovid®️), para manejo externo de pacientes adultos con #COVID19 agudo leve a moderado con riesgo de progresión estándar o de alto riesgo, vacunados o no: